Core courses for Toxicology SD progression

Textseite: 1 2 3 ()
Study Director Oversight and Interactions with the different groups - Interactions with Quality Assurance - Core 8.3
Study Director Oversight and Interactions with the different groups -Interactions with the technical staff - Core 8.2
Study Director Oversight and Interactions with the different groups - Study Directors Responsibilities - Core 8.1
Test Article/Item Requirements and Formulations - Practical Sessions - Shadow the formulations staff during a solution and suspension preparation - Core 7.5
Test Article/Item Requirements and Formulations - Supporting Documentation, Expiry/Retest Dates and Reserve Samples - Core 7.4
Test Article/Item Requirements and Formulations -Test Article/Item Requirements and Dose Formulations Calculations - Core 7.3
Test Article/Item Requirements and Formulations - Standard formulation methods and routinely used materials/vehicles- Core 7.2
Test Article/Item Requirements and Formulations- General Terminology for Formulations - OECD vs FDA- Core 7.1
Study Plan/Protocols and Amendments - Answering QA audits and Sponsor Comments related to study plan/protocol and amendments - Core 6.6
Study Plan/Protocols and Amendments - Overview of the Available Templates - Core 6.5
Study Plan/Protocols and Amendments - Study Plan Amendments - Core 6.4
Study Plan/Protocols and Amendments - Third Party Vendor Program - Core 6.3
Study Plan/Protocols and Amendments - Study Plans/Protocols- Development - Core 6.2
Study Plan/Protocols and Amendments - Study Plans/Protocols - Regulatory Requirements - Core 6.1
Study Set-up and Initiation - Pre-Study Meetings - Core 5.4
Study Set-up and Initiation - Overall Study Initiation and Scheduling Process - Core 5.3
Study Set-up and Initiation - Study Director Assignment and First Sponsor Communication - Core 5.2
Study Set-up and Initiation - Study Authorization Process - Core 5.1
Sponsor Interactions - Sponsor Interactions -Practice Scenarios - Core 4.3
Sponsor Interactions - Sponsor Interactions - Part II - Core 4.2
Sponsor Interactions - Sponsor Interactions - Part I - Core 4-1
Organization Overview: Global Laboratory Sciences - Onboarding 2-1
Organization Overview: Global Pathology - Onboarding 2-2
Organization Overview: Global Clinical Pathology - Onboarding 2-3
Organization Overview: Global Statistics - Onboarding 2-4
Textseite: 1 2 3 ()